Literature DB >> 8383597

Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin.

C P Taylor1, M G Vartanian, P W Yuen, C Bigge, N Suman-Chauhan, D R Hill.   

Abstract

3-Isobutyl GABA is a derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and is also structurally related to the novel anticonvulsant gabapentin. The S(+) enantiomer of 3-isobutyl GABA blocks maximal electroshock seizures in mice and also potently displaces tritiated gabapentin from a novel high-affinity binding site in rat brain membrane fractions. The R(-) enantiomer is much less active in both assays, suggesting that the gabapentin binding site is involved in the anticonvulsant activity of 3-isobutyl GABA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383597     DOI: 10.1016/0920-1211(93)90070-n

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  12 in total

1.  Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity.

Authors:  M J Field; R J Oles; L Singh
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Transport of pregabalin in rat intestine and Caco-2 monolayers.

Authors:  N Jezyk; C Li; B H Stewart; X Wu; H N Bockbrader; D Fleisher
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  New Horizons in the development of antiepileptic drugs: Innovative strategies.

Authors:  Wolfgang Löscher; Dieter Schmidt
Journal:  Epilepsy Res       Date:  2006-06       Impact factor: 3.045

Review 4.  The new generation of GABA enhancers. Potential in the treatment of epilepsy.

Authors:  S J Czuczwar; P N Patsalos
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  [The alpha2delta subunit of the voltage-dependent calcium channel. A new pharmaceutical target for psychiatry and neurology].

Authors:  D Wedekind; B Bandelow
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

6.  Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase.

Authors:  Y P Maneuf; A T McKnight
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

7.  Antiallodynic effect of pregabalin in rat models of sympathetically maintained and sympathetic independent neuropathic pain.

Authors:  Dong Woo Han; Tae Dong Kweon; Jong Seok Lee; Youn-Woo Lee
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 8.  Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.

Authors:  Karen L Goa; Eugene M Sorkin
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

9.  Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine.

Authors:  S Hadad; M Bialer
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

10.  Primary amines protect against retinal degeneration in mouse models of retinopathies.

Authors:  Akiko Maeda; Marcin Golczak; Yu Chen; Kiichiro Okano; Hideo Kohno; Satomi Shiose; Kaede Ishikawa; William Harte; Grazyna Palczewska; Tadao Maeda; Krzysztof Palczewski
Journal:  Nat Chem Biol       Date:  2011-12-25       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.